黎涛


[摘要] 目的 分析雌激素联合抗骨质疏松药物治疗绝经后妇女骨质疏松症的临床疗效。 方法 研究对象将本院2014年1月~2015年3月收治的75例绝经后妇女骨质疏松症患者纳入,抽签随机法分组。甲组患者予以抗骨质疏松药物干预,乙组患者在此基础上辅以雌激素治疗。连续用药24周,对比分析两组患者治疗效果、L2~4腰椎骨密度、药物副作用的差异。 结果 乙组治疗总有效率显著高于甲组,所有患者L2~4腰椎骨密度均有所上升,其中乙组L2~4腰椎骨密度明显高于甲组,且乙组药物副作用更少,上述指标对比差异均具有统计学意义(P<0.05)。 结论 雌激素联合抗骨质疏松药物治疗绝经后妇女骨质疏松症的临床疗效确切,可有效提高骨密度,减少药物副作用,值得推广。
[关键词] 雌激素;抗骨质疏松药物;绝经后妇女骨质疏松症;临床疗效
[中图分类号] R580 [文献标识码] B [文章编号] 2095-0616(2015)24-54-03
[Abstract] Objective To analyze the clinical curative effect of estrogen combined with anti-osteoporosis drug in treatment of osteoporosis in postmenopausal women. Methods 75 postmenopausal women with osteoporosis who were admitted in our hospital from January 2014 to March 2015 were included as research objects and they were allocated to the group A and group B according to random method.The group A was received anti-osteoporosis drug intervention while the group B was received adjuvant treatment of estrogen at the basis of group A.They were medicated for 24 weeks.Curative effect,L2-4 lumbar bone mineral density and side effects of drugs of patients in two groups were compared. Results Total effective rate of the group B was significantly higher than that of the group A L2~4 lumbar bone mineral density of all patients were increased.And L2-4 lumbar bone mineral density of group B was significantly higher than that of the group A.In addition, group B had fewer side effects of drugs.Differences in above indexes difference all had statistical significance (P<0.05). Conclusion Estrogen combined with anti-osteoporosis drug in treatment of osteoporosis in postmenopausal women has an accurate clinical curative effect.It can effectively improve bone mineral density and reduce the side effects of drugs,worthy of promotion.
[Key words] Estrogen;Anti-osteoporosis drug;Osteoporosis in postmenopausal women;Clinical curative effect
相对于男性来说,女性的骨量峰值比较低,尤其是绝经后妇女,由于其体内雌激素含量骤然降低,因而骨量也随之而降低,这是绝经后妇女易于出现骨质疏松的主要原因。其临床表现为肌肉疼痛,甚至出现抽搐等现象。在临床治疗上,主要是骨钙丢失的抑制和钙剂补充[1-3],对患者骨痛症状进行改善,降低骨折风险。本研究分析了雌激素联合抗骨质疏松药物治疗绝经后妇女骨质疏松症75例临床疗效,现将结果报告如下。
1 资料与方法
1.1 一般资料
研究对象选取本院2014年1月~2015年3月收治的75例绝经后妇女骨质疏松症患者,所有患者符合绝经后妇女骨质疏松诊断标准,将其他原因骨质疏松者排除。随机方法分组。甲组患者38例,岁数50~64岁,平均(59.1±5.9)岁;……